0001209191-23-052884.txt : 20231016 0001209191-23-052884.hdr.sgml : 20231016 20231016173007 ACCESSION NUMBER: 0001209191-23-052884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231012 FILED AS OF DATE: 20231016 DATE AS OF CHANGE: 20231016 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ndu Adora CENTRAL INDEX KEY: 0001865210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 231328068 MAIL ADDRESS: STREET 1: C/O DBV TECHNOLOGIES S.A. STREET 2: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12830 EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 12830 EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-12 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001865210 Ndu Adora C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 1 0 0 0 0 Common Stock 2023-10-12 4 M 0 4381 A 4381 D Restricted Stock Units 2023-10-12 4 M 0 4381 0.00 D Common Stock 4381 4381 D Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date. /s/ Austin D. Kim, Attorney-in-Fact 2023-10-16